Efficacy and safety of telitacicept in children with IgA vasculitis and IgA vasculitis nephritis: a single-center retrospective study
Telitacicept appears to be a promising therapy for children with IgAV and IgAVN, effectively inducing proteinuria remission, improving systemic symptoms, and reducing the use of steroids, with favorable safety.
Authors
- Pan‐Lin Shao (ORCID: https://orcid.org/0000-0001-7415-2195)
- Weibo Liang (ORCID: https://orcid.org/0000-0002-8487-3575)
- Jianhua Zhou
- Xueqing Ma
- Huiqing Yuan (ORCID: https://orcid.org/0000-0003-0763-9416)
- Yonghua He
- Liru Qiu (ORCID: https://orcid.org/0000-0002-9444-3464)
- Ling Guo
Institutions
- Wuhan Children's Hospital (CN)
Publication Details
- Journal
- Pediatric Rheumatology
- Published
- 2025-10-21
- DOI
- https://doi.org/10.1186/s12969-025-01159-3
- Citations
- 3
- Primary Topic
- Vasculitis and related conditions
- Type
- article
- Field-Weighted Citation Impact
- 4.56